The United States is a major contributor to the Blood Coagulation Testing Market, driven by its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and widespread adoption of diagnostic technologies. Increasing use of anticoagulant therapies, growing demand for point-of-care testing, and ongoing investments in laboratory automation continue to support the adoption of...